Contact

Representative before the EPO

Employment test 201 - 500 employees
Company dna zacco
operating since 2001
Headquarter in Copenhagen and 15 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Representative before the EPO

Company dna zacco norway as
no operation time available
1 office
active in Legal Services

Rita Lillegraven has worked on the following 3 EPO patent applications which have been published in the last five years:

EP11837647

METHODS OF TREATMENT USING LIPID COMPOUNDS

IPC classification:
A61K 31/19, A61P 3/04, A61P 3/06, A61P 3/10, A61P 9/10, C07C 57/03
Agent:
Rita Lillegraven, Zacco Norway AS
Status:
PATENT GRANTED
EP11807110

PARENTERAL FORMULATIONS OF ELACYTARABINE DERIVATIVES

IPC classification:
A61K 9/00, A61K 9/107, A61K 9/127, A61K 31/7056, A61K 47/48, C07H 19/06
Agent:
Rita Lillegraven, Zacco Norway AS
Status:
GRANT OF PATENT INTENDED
EP11734428

SALICYLATE FATTY ACID DERIVATIVES

IPC classification:
A61K 31/166, A61K 31/167, A61K 31/194, A61P 3/00, A61P 29/00, C07C 65/19, C07C 233/49, C07C 233/55, C07C 233/64, C07C 321/20
Agent:
Rita Lillegraven, Zacco Norway AS
Status:
APPLICATION DEEMED TO BE WITHDRAWN

Please Sign in to use this feature